TRADES
Latest Trades
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKF 20 Sep 2023 Sell DKNG DRAFTKINGS INC 45,509 0.1627
ARKF 20 Sep 2023 Buy RBLX ROBLOX CORP 46,424 0.1464
ARKF 20 Sep 2023 Buy TDOC TELADOC INC 26,872 0.0648
ARKG 20 Sep 2023 Buy TDOC TELADOC INC 57,862 0.0649
ARKG 20 Sep 2023 Buy RXRX RECURSION PHARMACEUTICALS 128,057 0.0569
ARKG 20 Sep 2023 Buy PACB PACIFIC BIOSCIENCES OF CALIF 85,256 0.0439
ARKG 20 Sep 2023 Buy DNA GINKGO BIOWORKS HOLDINGS INC 439,175 0.0432
ARKG 20 Sep 2023 Buy NTLA INTELLIA THERAPEUTICS INC 18,722 0.0351
ARKG 20 Sep 2023 Sell SDGR SCHRODINGER INC 6,842 0.0118
ARKG 20 Sep 2023 Buy SLGC SOMALOGIC INC 23,872 0.0030
ARKK 20 Sep 2023 Buy RBLX ROBLOX CORP 405,330 0.1489
ARKK 20 Sep 2023 Sell TSLA TESLA INC 32,080 0.1173
ARKK 20 Sep 2023 Sell DKNG DRAFTKINGS INC 276,690 0.1152
ARKK 20 Sep 2023 Buy TDOC TELADOC INC 225,703 0.0634
ARKK 20 Sep 2023 Buy DNA GINKGO BIOWORKS HOLDINGS INC 1,731,258 0.0426
ARKK 20 Sep 2023 Buy PACB PACIFIC BIOSCIENCES OF CALIF 322,577 0.0415
ARKK 20 Sep 2023 Buy NTLA INTELLIA THERAPEUTICS INC 85,777 0.0402
ARKQ 20 Sep 2023 Buy RKLB ROCKET LAB USA INC 327,466 0.1401
ARKQ 20 Sep 2023 Sell KMTUY KOMATSU LTD 12,500 0.0363
ARKQ 20 Sep 2023 Sell AVAV AEROVIRONMENT INC 2,330 0.0252
ARKQ 20 Sep 2023 Sell DDD 3D SYSTEMS CORP 5,231 0.0025
ARKW 20 Sep 2023 Sell DKNG DRAFTKINGS INC 71,027 0.1659
ARKW 20 Sep 2023 Buy RBLX ROBLOX CORP 74,292 0.1530
ARKW 20 Sep 2023 Buy TDOC TELADOC INC 40,605 0.0639
ARKX 20 Sep 2023 Buy RKLB ROCKET LAB USA INC 119,288 0.1982
ARKX 20 Sep 2023 Sell PRNT THE 3D PRINTING ETF 10,552 0.0807
ARKX 20 Sep 2023 Sell AVAV AEROVIRONMENT INC 512 0.0215
ARKX 20 Sep 2023 Sell DDD 3D SYSTEMS CORP 1,499 0.0028
ARKF 19 Sep 2023 Sell DKNG DRAFTKINGS INC 27,328 0.0950
ARKF 19 Sep 2023 Buy RBLX ROBLOX CORP 15,850 0.0486
ARKF 19 Sep 2023 Buy TDOC TELADOC INC 8,685 0.0205
ARKG 19 Sep 2023 Sell NVDA NVIDIA CORP 16,897 0.3971
ARKG 19 Sep 2023 Buy NTLA INTELLIA THERAPEUTICS INC 30,414 0.0566
ARKG 19 Sep 2023 Buy RXRX RECURSION PHARMACEUTICALS 112,885 0.0509
ARKG 19 Sep 2023 Buy PACB PACIFIC BIOSCIENCES OF CALIF 77,543 0.0392
ARKG 19 Sep 2023 Buy TDOC TELADOC INC 19,268 0.0216
ARKG 19 Sep 2023 Buy DNA GINKGO BIOWORKS HOLDINGS INC 192,825 0.0188
ARKG 19 Sep 2023 Sell SDGR SCHRODINGER INC 2,533 0.0044
ARKG 19 Sep 2023 Buy BEAM BEAM THERAPEUTICS INC 1,726 0.0022
ARKK 19 Sep 2023 Sell TSLA TESLA INC 77,170 0.2752
ARKK 19 Sep 2023 Sell DKNG DRAFTKINGS INC 153,787 0.0628
ARKK 19 Sep 2023 Buy NTLA INTELLIA THERAPEUTICS INC 120,141 0.0553
ARKK 19 Sep 2023 Buy RBLX ROBLOX CORP 135,285 0.0487
ARKK 19 Sep 2023 Buy PACB PACIFIC BIOSCIENCES OF CALIF 292,420 0.0366
ARKK 19 Sep 2023 Buy TDOC TELADOC INC 75,364 0.0209
ARKK 19 Sep 2023 Buy ACHR ARCHER AVIATION INC 249,484 0.0205
ARKK 19 Sep 2023 Buy DNA GINKGO BIOWORKS HOLDINGS INC 777,468 0.0188
ARKK 19 Sep 2023 Buy BEAM BEAM THERAPEUTICS INC 7,150 0.0023
ARKQ 19 Sep 2023 Buy RKLB ROCKET LAB USA INC 207,394 0.0898
ARKQ 19 Sep 2023 Sell KMTUY KOMATSU LTD 25,176 0.0732
ARKQ 19 Sep 2023 Sell AVAV AEROVIRONMENT INC 815 0.0088
ARKQ 19 Sep 2023 Sell DDD 3D SYSTEMS CORP 154 0.0001
ARKW 19 Sep 2023 Sell DKNG DRAFTKINGS INC 41,437 0.0948
ARKW 19 Sep 2023 Buy RBLX ROBLOX CORP 23,703 0.0478
ARKW 19 Sep 2023 Buy TDOC TELADOC INC 14,028 0.0218
ARKX 19 Sep 2023 Buy RKLB ROCKET LAB USA INC 73,742 0.1238
ARKX 19 Sep 2023 Sell PRNT THE 3D PRINTING ETF 13,494 0.1026
ARKX 19 Sep 2023 Sell AVAV AEROVIRONMENT INC 185 0.0077
ARKX 19 Sep 2023 Sell DDD 3D SYSTEMS CORP 46 0.0001
ARKG 18 Sep 2023 Buy RXRX RECURSION PHARMACEUTICALS 74,163 0.0324
ARKG 18 Sep 2023 Buy BEAM BEAM THERAPEUTICS INC 16,617 0.0213
ARKG 18 Sep 2023 Sell SDGR SCHRODINGER INC 10,099 0.0170
ARKK 18 Sep 2023 Buy BEAM BEAM THERAPEUTICS INC 69,130 0.0220
ARKQ 18 Sep 2023 Sell AVAV AEROVIRONMENT INC 1,852 0.0199
ARKQ 18 Sep 2023 Sell DDD 3D SYSTEMS CORP 288 0.0001
ARKX 18 Sep 2023 Sell AVAV AEROVIRONMENT INC 412 0.0172
ARKX 18 Sep 2023 Buy MKFG MARKFORGED HOLDING CORP 1,200 0.0005
ARKX 18 Sep 2023 Sell DDD 3D SYSTEMS CORP 112 0.0002
ARKG 15 Sep 2023 Buy RXRX RECURSION PHARMACEUTICALS 118,176 0.0513
ARKG 15 Sep 2023 Buy BEAM BEAM THERAPEUTICS INC 7,356 0.0095
ARKK 15 Sep 2023 Buy BEAM BEAM THERAPEUTICS INC 27,121 0.0088
ARKK 15 Sep 2023 Buy ACHR ARCHER AVIATION INC 12,280 0.0010
ARKQ 15 Sep 2023 Buy IRDM IRIDIUM COMMUNICATIONS INC 4,529 0.0205
ARKX 15 Sep 2023 Buy IRDM IRIDIUM COMMUNICATIONS INC 1,382 0.0244
ARKF 14 Sep 2023 Sell SHOP SHOPIFY INC 13,486 0.0954
ARKF 14 Sep 2023 Buy RBLX ROBLOX CORP 28,430 0.0890
ARKF 14 Sep 2023 Sell JD JD.COM INC 300 0.0011
ARKG 14 Sep 2023 Buy RXRX RECURSION PHARMACEUTICALS 38,016 0.0165
ARKG 14 Sep 2023 Buy BEAM BEAM THERAPEUTICS INC 3,515 0.0045
ARKG 14 Sep 2023 Sell SDGR SCHRODINGER INC 998 0.0017
ARKG 14 Sep 2023 Buy SLGC SOMALOGIC INC 299 0.0000
ARKK 14 Sep 2023 Buy RBLX ROBLOX CORP 257,593 0.0938
ARKK 14 Sep 2023 Sell TSLA TESLA INC 20,424 0.0727
ARKK 14 Sep 2023 Buy BEAM BEAM THERAPEUTICS INC 14,045 0.0046
ARKQ 14 Sep 2023 Sell DDD 3D SYSTEMS CORP 32,623 0.0168
ARKW 14 Sep 2023 Buy GENI GENIUS SPORTS LTD 1,274,652 0.5001
ARKW 14 Sep 2023 Sell SHOP SHOPIFY INC 52,983 0.2459
ARKW 14 Sep 2023 Sell TSLA TESLA INC 9,965 0.1999
ARKW 14 Sep 2023 Sell DKNG DRAFTKINGS INC 66,149 0.1510
ARKW 14 Sep 2023 Buy RBLX ROBLOX CORP 46,007 0.0945
ARKX 14 Sep 2023 Sell DDD 3D SYSTEMS CORP 9,634 0.0193
ARKX 14 Sep 2023 Buy MKFG MARKFORGED HOLDING CORP 100 0.0000
ARKF 13 Sep 2023 Sell SHOP SHOPIFY INC 23,498 0.1629
ARKF 13 Sep 2023 Buy RBLX ROBLOX CORP 52,852 0.1608
ARKF 13 Sep 2023 Sell JD JD.COM INC 2,569 0.0089
ARKG 13 Sep 2023 Buy BEAM BEAM THERAPEUTICS INC 30,419 0.0385
ARKG 13 Sep 2023 Sell SDGR SCHRODINGER INC 12,376 0.0212
ARKK 13 Sep 2023 Sell TSLA TESLA INC 51,155 0.1793
ARKK 13 Sep 2023 Buy RBLX ROBLOX CORP 458,265 0.1636
ARKK 13 Sep 2023 Sell DKNG DRAFTKINGS INC 178,672 0.0709
Latest Blogs
ARK by Cathie Wood is still suffering a year after its apex.

Cathie Wood's flagship exchange-traded fund hit an all-time high in February of this year. Her preferred disruptive-tech chasing strategy may still be in for a lot of suffering after a year and a 53 percent fall.

After a dramatic decline last month, the ARK Innovation ETF (ticker: ARKK) has steadied off - it's practically flat in February – but the headwinds surrounding its speculative growth picks are just becoming more vital. Many businesses that thrived during the pandemic are being hammered by the economic reopening, not only because yields are rising as investors prepare for the US Federal Reserve to raise interest rates, which is terrible news for unprofitable businesses, but also because the economic reopening is hammering many of the businesses that thrived during the pandemic.

Roku, Teladoc, and Zoom, all winners in the work-from-home era, have had their stock prices plummet by as much as 74% in the past year.

Short bets against ARK, according to IHS Markit data, hit a fresh high of 11.4 percent of outstanding shares this week. The Tuttle Capital Short Innovation ETF (SARK), which beats the ARK, now has assets worth more than $US300 million ($416 million).

"Those equities are supported by speculation, and speculation pays less well when the Fed raises rates," said Brent Schutte, chief investment strategist at Northwestern Mutual Wealth Management Co. "Much of what's happening in the market reminds me of what happened in the late 1990s when market segments were bid up to levels based on future assumptions."

Because its price chart resembles that of the Nasdaq index of technology businesses from more than two decades ago, analogies to that period and the dot-com implosion that followed are becoming more common in discussions of ARK.

"Today marks the 253rd trading day from ARK's all-time high," Jessica Rabe, co-founder of DataTrek Research, wrote in a Tuesday note, "while the Nasdaq was down 60% from its dot-com bubble top on the same day in 2001."

"If 2000/2001 analog holds, we should see ARK continuing to fall over the following three weeks. The Nasdaq dropped 18.7% in the next 16 trading days "recent."

Net flows are positive.

The better news for investors and Ms. Wood is that there may be some immediate respite. The Nasdaq rose 41% in six weeks in 2001 before falling.

The ARK Investment Management did not respond to a request for comment.

Most of ARK's $US15 billion asset loss has been attributed to bad performance, a plus for the company. Since the fund achieved an intraday high of $US159.70 a year ago this week, investors have withdrawn only around $US465 million, and ARK's net flows this year are positive despite a more than 20% drop.

This exceptional loyalty prevents a worsening situation and allows Wood's approach to recovering. The star fund manager has consistently emphasized that her funds have a five-year investment horizon and that she believes in many good options.

Mr. Schutte, on the other hand, says the drop is understandable because several of the company's biggest bets, such as Teladoc and Zoom, are becoming less significant as COVID-19 approaches.

"During the pandemic, there were a lot of questions about what would happen to society and how we'd go about our lives," he added.

"You drew in new investors who wanted to know "what are the upcoming themes I should invest in?" I believe you got a washout of it as well."

On Friday, Cathie Wood sold $148.9 million worth of Palantir stock, halving her exposure.

Ark Investment Management, run by Cathie Wood, sold more Palantir Technologies Inc PLTR -6.39 percent shares on Friday, cutting its stake in the Peter Thiel-backed company.

According to Friday's closing price, the famous investment management firm sold 13.5 million shares of the big data company, valued at $148.9 million.

Palantir's stock fell 6.4 percent to $11.02 per share on Friday. The stock has lost 16% of its value in the last week.

Before Friday's trade, Ark Invest held 25.53 million shares in Palantir, suggesting that the famous stock picker had trimmed over 52 percent of its total keeping a day later.

After the business disclosed lower-than-expected fourth-quarter earnings before the market opened on Thursday, Ark Invest, located in St. Petersburg, California, dumped shares in Palantir for the second time.

The software firm, well-known for its work with government organizations, posted earnings of 2 cents per share, falling short of the analyst consensus of 4 cents. The company recorded quarterly revenues of $432.87 million, higher than the $417.69 million predicted by analysts.

Palantir's stock had been sold for 4.77 million shares by the investment firm the day before.

All six of Ark Invest's active exchange-traded funds own Palantir stock, including the flagship Ark Innovation ETF ARKK -4.88 percent.

Before the recent sell-off, Ark Invest had been stockpiling Palantir shares for months.

Cathie Wood appeared on television to defend her ARK funds' dismal performance. It didn't go quite as planned.

The Ark Innovation ETF (ARKK), Cathie Wood's flagship fund, is down 30% year to date and more volatile than almost any other fund on the market. On CNBC's Halftime Report, Wood jumped at the chance to defend the fund and its deflated price, which is currently $68.80, down from $155 a year ago.

"We've seen a significant decline," Wood said, adding, "We feel innovation is at bargain basement zone." Even though her ETF was underperforming, she emphasized that her companies were still "very inexpensive" and that the current fund loss was temporary. When the call's 40 free minutes were finished, Zoom gave her an extra 10 minutes to complete the interview.

Having Zoom check to see whether she was "running out of time?" Wood, who has been aggressively buying up shares in Zoom and other IT firms that have fallen from their pandemic highs, was unhappy. Zoom, like Wood's other significant tech holdings, Teladoc Health, Roku, and Roblox, is down 20% to 40% year to date as investors worry about rising interest and inflation rates.

However, a significant chunk of the interview was devoted to a personal assault on Cathie Wood, who was named the most excellent stock picker in 2020 by Bloomberg's then-Editor-in-Chief Matthew Winkler after correctly forecasting that Tesla will one day be valued at more than $1 trillion.

Wood bluntly ignored Tuttle Capital Management's Short Innovation ETF (SARK), which tracks the inverse performance of ARKK using swaps contracts for the sole purpose of betting against Cathie Wood's selections. "They're not conducting any research." She explained, "All they're doing is shorting innovation."

Of course, SARK is betting against Cathie Woods, not on innovation. "Well, we stand for invention," Wood responded. The SARK ETF has gained 55 percent since its debut, whereas the ARKK ETF has declined by 42 percent.

Tuttle Capital Management CEO Matthew Tuttle chimed in on the SARK ETF, calling it a "tool" for investors. According to SARK, "to convey a negative view of the market, innovative enterprises, the current rising rate environment, or a [specific] portfolio manager if they wish." "It's un-American not to have options in the marketplace," Tuttle told Insider on Thursday.

In any event, Wood is making progress. Her main concern currently is bearish calls on her ETF. "Our major concern is that our investors convert temporary losses into long-term losses," Wood continued.